Professor Ju-Lee Oei
Professor Ju-Lee Oei is the inaugural Chair of Neonatology at Mater, working across Mater Mothers’ hospitals and Mater Research to advance healthcare outcomes for mothers and babies.
Prof Oei has extensive research and clinical expertise in the resuscitation of sick newborns, and in the care of mothers, babies and families affected by drugs of addiction and dependency.
She has authored more than 190 scientific papers, mentored more than 70 students and neonatal trainees and is currently the chief investigator of two multi-centre trials for the use of oxygen in newborn babies.
Prof Oei collaborates with researchers, clinicians and policy makers from around Australia and the world, and has contributed to state and national guidelines for the management of neonatal abstinence syndrome, as well as guidelines for the American Breast-Feeding Medical Association for maternal drug use.
As Chief Investigator on the NHMRC-funded TORPIDO 3060 Study, Prof Oei has secured more than $15 million in competitive research funding and currently serves on the NHMRC grant review panel for project and leadership grants.
For more than six years, she has led a highly productive perinatal data linkage team, as well as an international resuscitation research group, influencing national and global neonatal resuscitation guidelines.
Prof Oei is also Conjoint Professor at the University of New South Wales and Honorary Associate Professor at the NHMRC Clinical Trials Centre at the University of Sydney.
This newly created position is supported by Mater Foundation through the Nine Telethon for Mater Little Miracles.
Funding
Prof Oei was awarded a 2025 Nine Telethon Perinatal Research Grant for a Chair in Neonatology for $663,588 over one year. Prof Oei is an international leader in the resuscitation of sick newborns, and in the care of mothers, babies and families affected by drugs of addiction and dependency. Her research will drive major advancements in neonatal research and clinical practice, enhancing Mater’s reputation as a world leader in mother and baby health.
